NME1 and breast carcinoma: NMac1 has been reported as having anti-metastatic potential by activating Nm23-H1 having NDP kinase (NDPK) enzymatic activity with direct interaction to C-terminal in vitro and inhibits breast cancer metastasis in vivo19.